text: Financing Cash Flow Activities
text: Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
text: Net cash provided by financing activities – continuing operations increased during the year ended December 31, 2019 primarily due to inflows resulting from (i) the issuance of the 0.875% Convertible Senior Notes, (ii) lower credit facility payments, partially offset with less credit facility borrowings and (iii) a decrease in the repurchase of common stock. These were partially offset by the purchase of the remaining minority interest in Pulse8 during 2019.
text: Year Ended December 31, 2018 Compared with the Year Ended December 31, 2017
text: We used cash in financing activities – continuing operations during the year ended December 31, 2018 compared with cash inflows from financing activities – continuing operations during the year ended December 31, 2017, which was primarily driven by higher repayments of borrowings outstanding under our senior secured credit facility and higher common stock repurchases. We used a portion of the proceeds from the sale of our investment in Netsmart to repay balances outstanding under our senior secured credit facilities at the end of 2018. We borrowed funds in 2018 to purchase Practice Fusion and Health Grid and to acquire the remaining outstanding minority interest in which we initially acquired a controlling interest in April 2015.
text: Net cash provided by financing activities – discontinued operations increased during the year ended December 31, 2018 compared with the prior year primarily due to higher borrowings by Netsmart used to finance business acquisitions.

Table:
Year Ended December 31,
(In thousands)
2019
2018
2017
2019 $ Change from 2018
2018 $ Change from 2017
Proceeds from sale or issuance of common stock
$0
$1,283
$1,568
$(1,283)
$(285)
Taxes paid related to net share settlement of equity awards
(7,286)
(9,466)
(7,269)
2,180
(2,197)
Proceeds from issuance of 0.875% Convertible Senior Notes
218,000
0
0
218,000
0
Payments for issuance costs on 0.875% Convertible Senior Notes
(5,445)
0
0
(5,445)
0
Payments for capped call transaction on 0.875% Convertible Senior Notes
(17,222)
0
0
(17,222)
0
Credit facility payments
(220,000)
(713,751)
(138,139)
493,751
(575,612)
Credit facility borrowings, net of issuance costs
279,241
430,843
325,001
(151,602)
105,842
Repurchase of common stock
(111,460)
(138,928)
(12,077)
27,468
(126,851)
Payment of acquisition and other financing obligations
(14,685)
(5,198)
(1,283)
(9,487)
(3,915)
Purchases of subsidiary shares owned by non-controlling interest
(53,800)
(7,198)
0
(46,602)
(7,198)
Net cash provided by (used in) financing activities - continuing operations
67,343
(442,415)
167,801
509,758
(610,216)
Net cash provided by (used in) financing activities - discontinued operations
0
149,432
30,784
(149,432)
118,648
Net cash provided (used in) by financing activities
$67,343
$(292,983)
$198,585
$360,326
$(491,568)

Questions:
question: What is the Proceeds from sale or issuance of common stock in 2019?
answer: $0
scale: thousand
question: What is the Proceeds from sale or issuance of common stock in 2018?
answer: $1,283
scale: thousand
question: What is the Proceeds from sale or issuance of common stock in 2017?
answer: $1,568
scale: thousand
question: What is the change in Taxes paid related to net share settlement of equity awards from 2019 to 2018?
answer: -2180
derivation: 7,286-9,466
scale: thousand
question: What is the change in Credit facility payments from 2019 to 2018?
answer: -493751
derivation: 220,000-713,751
scale: thousand
question: What is the change in Payment of acquisition and other financing obligations from 2019 to 2018?
answer: 9487
derivation: 14,685-5,198
scale: thousand